Physician profile
Mark Gurley
NPI 1285751818
$8,052.15
in general payments reported to CMS, 2019-2025
30 companies · $1,088 in 2025
The $1,088 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,561 · 2020: $363 · 2021: $820 · 2022: $920 · 2023: $412 · 2024: $888 · 2025: $1,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,257 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,257.07 |
| Education | $131.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $3,112.45 | 2019-2022 | |
| Stryker Corporation | $1,220.13 | 2019-2022 | |
| Genzyme Corporation | $756.90 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $614.12 | 2019-2025 | Dupixent, Libtayo |
| Acclarent, INC | $494.35 | 2019-2024 | Acclarent Aera |
| Glaxosmithkline, LLC. | $418.70 | 2022-2025 | Nucala |
| Integra Lifesciences Corporation | $273.00 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $157.62 | 2019-2023 | |
| Optinose US, INC. | $134.51 | 2020-2025 | |
| Medtronic, INC. | $134.48 | 2022-2025 | Propel, Slide-On Endosheath |
| Sanofi-Aventis U.S. LLC | $111.94 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $110.16 | 2019-2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $70.65 | 2019-2025 | |
| Organogenesis INC. | $43.96 | 2024 | |
| Inspire Medical Systems, INC. | $38.12 | 2024-2025 | Inspire |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $37.68 | 2025 | Tezspire |
| Davol INC. | $36.60 | 2020 | |
| Acera Surgical, INC. | $35.80 | 2024-2025 | Restrata Wound Matrix |
| Hikma Pharmaceuticals USA | $33.27 | 2024-2025 | Ryaltris |
| Neurent Medical Limited | $28.73 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Ars Pharmaceuticals Operations, INC. | $25.44 | 2025 | Neffy |
| Baxter Healthcare | $24.65 | 2025 | Perclot |
| Alk-Abello, INC | $23.00 | 2021 | |
| Covidien Lp | $20.80 | 2019 | |
| Phadia US INC. | $19.89 | 2024 | Immunocap |
| Greer Laboratories, INC. | $19.68 | 2019 | |
| Cook Medical LLC | $16.17 | 2021 | |
| Xoran Technologies LLC | $14.18 | 2020 | |
| Ambu INC. | $13.44 | 2020 | |
| Olympus America INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gurley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.